NXTS · Registration Statement (Form S-1) · Filed July 13, 2026

Nexentis Technologies Inc — S-1 exhibit

ex23-2.htm

Nexentis Technologies Inc on Boardroom Alpha

Exhibit 23.2

Kost Forer Gabbay & Kasierer

144 Menachem Begin Road, Building A,

Tel-Aviv 6492102, Israel

Tel: +972-3-6232525

Fax: +972-3-5622555

ey.com

Consent of Independent Auditors

We consent to the reference to our firm under the caption “Experts” in the Registration Statement on Form S-1 and related Prospectus of Nexentis Technologies Inc. for the registration of its common stock and to the incorporation by reference therein of our report dated May 12, 2025, with respect to the financial statements of MitoCareX Bio Ltd. included in Nexentis Technologies Inc. Current Report on Form 8-K/A dated November 12, 2025, filed with the Securities and Exchange Commission.

/s/ KOST FORER GABBAY & KASIERER
A member of EY Global

Tel Aviv, Israel
July 13, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer